Pharma Companies Pharmacy Vaccine 
World of DTC Marketing
FEBRUARY 28, 2021
SUMMARY: Pharma companies, like J&J, have received criticism for engaging in illegal activities, such as providing kickbacks and bribes, knowingly shipping adulterated or contaminated drugs to pharmacies, and marketing drugs for unapproved uses. Can a COVID-19 vaccine approval suddenly erase that? The answer is NO.
World of DTC Marketing
APRIL 21, 2021
The amount of money Pfizer is going to make from their vaccine borders on obscene while PBMs quietly take a cut of every Rx transaction without really adding any value. ” J&J has had problems in the past, but they’re trying to be an ethical and responsible pharma company. Pharma is a big business.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
World of DTC Marketing
FEBRUARY 21, 2022
Pfizer expects to make as much as $22bn from its new Covid pill this year, on top of $37bn it made in 2021 from the vaccine. The study adds further evidence to the idea that drug copay cards are a great short-term deal for patients — and especially the pharma companies that promote them — but a wrong long-term value for healthcare costs.
Pharmaceutical Technology
JUNE 30, 2022
While private pharma companies also take part in such efforts, their efforts has largely been limited to donating assets or distributing treatments. In Muratov’s opinion, this was reflective of a wider pattern seen in almost any other field of research, which could now change with the development of Covid-19 vaccines and antivirals.
pharmaphorum
DECEMBER 1, 2020
Thanks to the convergence of tech and health, the future of healthcare places the patient directly in the driver seat, able to track their health stats, monitor and manage conditions, engage with providers and connect with pharmacies all within a digital platform. About the author. Omri Shor is the CEO of Medisafe.
pharmaphorum
FEBRUARY 25, 2022
Pharma companies are now household names, having been thrust into the public’s consciousness after dominating the headlines through the pandemic. These efforts, as Nadhim Zahawi rightly said when he was Vaccines Minister, have led to the life sciences and pharma industry becoming a UK national treasure.
pharmaphorum
SEPTEMBER 9, 2022
Rising global temperatures will, for example, enhance the spread of mosquito-borne diseases like malaria and Zika, increasing the need for effective vaccines. Just as in the wake of COVID-19, the world will look to pharma to fulfil its public health needs. “Any Vulnerability . Making plans is not enough.
Expert insights. Personalized for you.
180 
Let's personalize your content